The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand - GBI Research Reports

The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand

The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand - GBI Research Reports
The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand
Published Jan 31, 2010
142 pages — Published Jan 31, 2010
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive DemandSummaryGBI Research's new report, 'The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand' provides key data, information and analysis on the global in-vitro diagnostics market, a key segment within the medical equipment industry. This medical device report provides market landscape, competitive landscape and market trends information on seven in-vitro diagnostics market categories - Clinical Chemistry, Genetic Testing, Histology and Cytology, Immuno Chemistry, Infectious Immunology, Microbiology Culture and Haematology. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.Scope- Key geographies including the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Belgium, Netherlands, Japan, China, India, Australia, Taiwan, republic of Korea, Brazil, Argentina, Mexico, Israel and South Africa.- Global Market size and company share data for seven In-Vitro Diagnostics market categories - clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture and haematology.- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.- Qualitative analysis of key market trends, market drivers and restraints by categories and segments.- Competitive landscape and key company profiles. Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, Becton, Dickinson (BD), Bio-Rad Laboratories, Inverness Medical Innovations, Sysmex, Gen-Probe and Dade Behring.- Key in-pipeline products and technologies expected to hit the global In-Vitro Diagnostics market in the near future.Reasons to buy- Develop business strategies by understanding the trends and developments that are driving the In-Vitro Diagnostics market globally. - Design and develop your product development, marketing and sales strategies. - Exploit M&A opportunities by identifying market players with the most innovative pipeline. Develop market-entry and market expansion strategies. - Identify key players best positioned to take advantage of the emerging market opportunities. - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return. - What's the next big thing in the In-Vitro Diagnostics market landscape? - Identify, understand and capitalize - Make more informed business decisions from the insightful and in-depth analysis of the In-Vitro Diagnostics market and the factors shaping it.

  
Source:
Document ID
GBIME0002MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
1 Table of Contents 38
1.1 List of Tables72
1.2 List of Figures 92
2 Introduction and Overview111
2.1 In-Vitro-Diagnostics (IVD) Overview111
3 Global In-Vitro Diagnostics (IVD) Market: Market Characterization1213
3.1 Global In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 2009121
3.2 Global In-Vitro Diagnostics (IVD) Market, Revenue Forecasts ($m), 2009 2016131
3.3 Global In-Vitro Diagnostics (IVD) Market, Company Share (%), 2008141
3.4 Global In-Vitro Diagnostics (IVD) Market, Key Market Trends151
3.4.1 Entry of Diagnostic Imaging Players into the In-Vitro Diagnostics (IVD) Market Has Set Stage for New Technologies to Be Developed By Marrying the Two Disciplines151
3.4.2 Large Number of Private Equity/ Venture Capital (PE/VC) Investments and Collaborations in the In-Vitro Diagnostics (IVD) Sector to Fuel Innovation161
3.4.3 Consolidation of Laboratories across the World161
3.5 Global In-Vitro Diagnostics (IVD) Market: Key Technology Trends171
3.5.1 Emerging Technologies for Cutting Lab Costs171
3.5.1.1 Point of Care Testing (POCT) Technology171
3.5.1.2 Automation181
3.5.2 New Technologies Improve Speed and Accuracy181
3.5.2.1 Advanced Technologies Such As Miniaturization of Rapids Tests Expand Use of POCT to Critical Care and Emergency Medicine181
3.5.2.2 Growth of Molecular Diagnostics Is Facilitating Early Disease Detection181
Rising Emphasis on Patient Centric, Personalized Medicine to Accelerate Development of Companion Diagnostics 191
3.6 Global In-Vitro Diagnostics (IVD) Market, Market Drivers201
3.6.1 Economic Market Drivers201
3.6.1.1 Emerging Countries to Play an Important Role in Driving Growth201
3.6.1.2 Need to Control Costs at Laboratories to Drive Adoption of New Processes and Instruments201
3.6.1.3 Retail Testing Services Will Have a Positive Impact on In-Vitro Diagnostics (IVD) Market, As Accessibility to the Common Man Improves211
3.6.2 Technological Market Drivers221
3.6.2.1 Growth in New Technologies Such As Molecular Diagnostics and Rapid Tests to Drive In-Vitro Diagnostics (IVD) Market221
3.6.3 Regulatory Market Drivers221
3.6.3.1 Emergence of Laws for Patent Protection221
3.6.3.2 Easing Regulations to Drive Decentralized Testing221
3.6.4 Social Market Drivers221
3.6.4.1 Paradigm Shift towards Preventive Medicine to Drive Growth in Diagnostics for Early Detection and Screening221
3.6.4.2 Patient Centric Medicine with Better Informed Consumers Assumes More Significant Role in Managing Their Health231
3.6.4.3 Ageing Population to Drive Demand for In-Vitro Diagnostic (IVD) Tests for Monitoring and Disease Detection231
3.7 In-Vitro Diagnostics (IVD) Market, Market Restraints231
3.7.1 Economic Market Restraints231
3.7.1.1 Healthcare Budget Deficits in the Majority of Developed Nations to Lead to Rationalization of Testing 231
3.7.1.2 Pricing Pressures, Low Levels Of Reimbursement, Reimbursement Cuts, and Lack of Monetary Incentives for New Tests to Impede Market Growth231
3.7.1.3 Local Players for Consumables Put Pricing Pressures on International Players in Developing Nations231
3.7.2 Social Market Restraints241
3.7.2.1 Shortage of Skilled Labor a Major Problem for Laboratories241
4 Global In-Vitro Diagnostics (IVD) Market: Category Analysis and Forecasts2530
4.1 Clinical Chemistry Market: Market Characterization251
4.1.1 Global Clinical Chemistry Market, Revenue ($m), 2002 2009251
4.1.2 Global Clinical Chemistry Market, Revenue Forecasts ($m), 2009 2016261
4.1.3 Global Clinical Chemistry Market, Company Share (%), 2008271
4.1.4 Clinical Chemistry Market: Market Drivers281
4.1.4.1 Emerging Economies Such As India, Brazil and China Are Expected To Drive Growth in the Global Clinical Chemistry Market281
4.1.4.2 Need for Greater Productivity and Throughput Gains and Need for Cost Saving Will Drive Segments Such As Point of Care (POC), Rapid Tests, and Automated Analyzers281
4.1.4.3 Need for Integration Will Drive Purchases of Integrated Chemical Analyzers281
4.1.4.4 Ageing Population and Consequent Rise in the Incidence of Chronic and Infectious Diseases Will Continue To Drive Market Growth281
4.1.5 Clinical Chemistry Market: Market Restraints281
4.1.5.1 Market Maturity Is Putting Downward Pricing Pressures On Vendors281
4.1.5.2 Revised FDA Guidelines and Increased Compliance Expected To Adversely Impact Small Laboratories291
4.2 Immuno Chemistry Market: Market Characterization291
4.2.1 Global Immuno Chemistry Market, Revenue ($m), 2002 2009292
4.2.2 Global Immuno Chemistry Market, Revenue Forecast ($m), 2009 2016311
4.2.3 Global Immuno Chemistry Market, Company Share (%), 2008321
4.2.4 Immuno Chemistry Market: Market Drivers331
4.2.4.1 Emerging Economies to Drive Growth in Global Immuno Chemistry Market331
4.2.4.2 Advances in Molecular Biology, Discovery of New Biomarkers and New Applications to Drive Future Growth331
4.2.4.3 Technological Innovations Such As Miniaturization of Biosensors, Microfluidics and Nanotechnology Leading To Development of New, Innovative Immunodiagnostic Rapid Tests331
4.2.4.4 Pharmacogenomics and Need for Personalized Testing to Determine Drug Response to Drive Immuno Chemistry Market in the Future331
4.2.4.5 Increasing Awareness of Early Screening, Detection and Diagnosis Fuelling Growth341
4.2.5 Immuno Chemistry Market: Market Restraints341
4.2.5.1 Low Reimbursement Rates Hamper the Development and Uptake of New Immunoassays341
4.3 Haematology Market: Market Characterization351
4.3.1 Global Haematology Market, Revenues ($m), 2002 2009351
4.3.2 Global Haematology Market, Revenue Forecasts ($m), 2009 2016361
4.3.3 Global Haematology Market, Company Share (%), 2008371
4.3.4 Haematology Market: Market Drivers371
4.3.4.1 Brazil, India and Japan to Lead Growth in Global Haematology Market371
4.3.4.2 Technological advancements which aid in Miniaturization, Enhanced Menu Options and Improved Throughput Will Drive Market381
4.3.4.3 Adoption of Automated Analyzers in Small-to-Medium Laboratories Will Lead to Market Growth381
4.3.5 Haematology Market: Market Restraints381
4.3.5.1 Intense Competition Put Downward Pressure on Profit Margins381
4.4 Histology and Cytology Market: Market Characterization391
4.4.1 Global Histology and Cytology Market, Revenue ($m), 2002 2009391
4.4.2 Global Histology and Cytology Market, Revenue Forecasts ($m), 2009 2016401
4.4.3 Global Histology and Cytology Market, Company Share (%), 2008411
4.4.4 Histology and Cytology Market: Market Drivers421
4.4.4.1 Asia Pacific and Europe to Drive Market Demand421
4.4.4.2 Advances in Cell/Tissue Staining, Biopsy in Cancer Detection and Diagnosis and Automation Technology Will Drive Market Growth421
4.4.5 Histology and Cytology Market: Market Restraints421
4.4.5.1 New Molecular, Non Invasive Blood Tests Threaten To Cannibalize Market for Detection of Infectious Diseases421
4.4.5.2 Consolidated Market Creates Entry Barriers for Small Players421
4.5 Microbiology Culture Market: Market Characterization431
4.5.1 Global Microbiology Culture Market, Revenue ($m), 2002 2009431
4.5.2 Global Microbiology Culture Market, Revenue Forecasts ($m), 2009 2016441
4.5.3 Global Microbiology Culture Market, Company Share (%), 2008451
4.5.4 Global Microbiology Culture Market: Market Drivers451
4.5.4.1 High growth in China and Brazil to drive market451
4.5.4.2 High Prevalence of Infectious Diseases Will Sustain Market Growth In The Future451
4.5.4.3 Improved Efficiency, Time Savings and Lack of Skilled Labor Will Lead to Increased Adoption of Automation 461
4.5.5 Microbiology Culture Market: Market Restraints461
4.5.5.1 Molecular Diagnostics Are Increasingly Replacing the Time Consuming Process of Bacterial Culture 461
4.6 Infectious Immunology Market: Market Characterization471
4.6.1 Global Infectious Immunology Market, Revenue ($m), 2002 2009471
4.6.2 Global Infectious Immunology Market, Revenue Forecasts ($m), 2009 2016481
4.6.3 Global Infectious Immunology Market, Company Share (%), 2008491
4.6.4 Global Infectious Immunology Market: Market Drivers491
4.6.4.1 Emergence of Highly Infectious Mutant Strains Of Pathogens Will Drive the Demand for Appropriate Diagnostics to Contain the Spread of These Agents 491
4.6.4.2 New Cases of Humans Infected With Animal Pathogens Will Lead to High Demand for Diagnostic Tests501
4.6.5 Global Infectious Immunology Market: Market Restraints501
4.6.5.1 Reimbursement Systems That Do Not Provide Incentives to New Tests Will Hold Back Market Growth501
4.7 Genetic Testing Market: Market Characterization511
4.7.1 Global Genetic Testing Market, Revenue ($m), 2002 2009511
4.7.2 Global Genetic Testing Market, Revenue Forecasts ($m), 2009 2016521
4.7.3 Global Genetic Testing Market, Company Share (%), 2008531
4.7.4 Global Genetic Testing Market: Market Drivers531
4.7.4.1 Rapid Adoption of Genetic Testing For Screening Genetic Disorders and High Risk Patients in Brazil, India and China to Drive Market531
4.7.4.2 Advances in Genetics and Proteomics, and Better Understanding of Underlying Genetic Causes of Diseases Will Drive Test Volumes through New Tests531
4.7.4.3 Rising Awareness Driven By Direct To Consumer Marketing Will Drive Market Growth541
4.7.4.4 Pharmacogenomic Testing To Play a Significant Role in Driving the Genetic Testing Market 541
4.7.5 Global Genetic Testing Market: Market Restraints541
4.7.5.1 Prohibitive Costs for Genetic Tests Likely To Temper High Growth in Demand In The Future541
4.7.5.2 Lack of Standardization of Genetic Tests Creates Doubts about the Validity of Tests541
5 Global In-Vitro Diagnostics (IVD) Market: Country Analysis and Forecasts5549
5.1 Global In-Vitro Diagnostics (IVD)Market: Geographic Trends Analysis551
5.2 Market Characterization, North America, 2002 2016561
5.2.1 The US In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 2009561
5.2.2 The US In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 2016571
5.2.3 Canada In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 2009582
5.2.4 North America In-Vitro Diagnostics (IVD) Market, Market Drivers601
5.2.4.1 Ageing Population and Technological Innovation to Drive Testing Volumes601
5.2.4.2 Point Of Care and Satellite Laboratory Testing In Non-Traditional, Ambulatory Settings to Gain Increased Focus In The Future601
5.2.5 North America In-Vitro Diagnostics (IVD) Market, Market Restraints601
5.2.5.1 Heightened Regulatory Oversight on Personalized Testing Such As Direct to Consumer Genetic Testing To Hamper Growth of Private Players601
5.3 Market Characterization, Europe, 2002 2016611
5.3.1 The UK In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 2009611
5.3.2 The UK In-Vitro Diagnostics (IVD) Market, Revenues ($m), 2009 2016621
5.3.3 Germany In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 2009631
5.3.4 Germany In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 2016641
5.3.5 France In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 2009652
5.3.6 France In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 2016671
5.3.7 Italy In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 2009681
5.3.8 Italy In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 2016691
5.3.9 Spain In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 2009701
5.3.10 Spain In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 2016711
5.3.11 Belgium In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 2009721
5.3.12 Belgium In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 2016731
5.3.13 The Netherlands In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 2009741
5.3.14 The Netherlands In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 2016751
5.3.15 Europe In-Vitro Diagnostics (IVD) Market, Market Drivers761
5.3.15.1 Ageing Population to Drive Growth Due To Increase in Routine Testing761
5.3.15.2 Increasing Surveillance for Hospital Acquired Infections to Drive Screening Kits761
5.3.15.3 Consolidation of Laboratories to Create Opportunities in the Laboratory Automation for Managing Pre-Analytical and Post-Analytical Phases761
5.3.16 Europe In-Vitro Diagnostics (IVD) Market, Market Restraints761
Healthcare Budget Deficits in the Majority of European Markets to Continue To Lead to Rationalization of Testing 761
5.3.16.2 Purchase Organizations Will Leverage Their Position To Negotiate Low Cost Contracts, Leading To Thinning Margins.771
5.4 Market Characterization, Asia Pacific, 2002 2016771
5.4.1 Japan In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 2009 771
5.4.2 Japan In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 2016781
5.4.3 China In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 2009792
5.4.4 China In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 2016811
5.4.5 India In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 2009821
5.4.6 India In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 2016831
5.4.7 Australia In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 2009841
5.4.8 Australia In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 2016851
5.4.9 Taiwan In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 2009861
5.4.10 Taiwan In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 2016871
5.4.11 Republic of Korea In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 2009881
5.4.12 Republic of Korea In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 2016891
5.4.13 Asia Pacific In-Vitro Diagnostics (IVD) Market, Market Drivers901
5.4.13.1 Ageing Population Will Drive Growth in Developed Countries Such As Japan and Australia, While Population Growth Will Drive Emerging Economies901
5.4.13.2 Increased Technology Adoption will be a Uniform Trend Driving the Sales of IVD Instruments In the Future901
5.4.14 Asia Pacific In-Vitro Diagnostics (IVD) Market, Market Restraints911
5.4.14.1 Laboratory Consolidation to Put a Further Squeeze on the In-Vitro Diagnostics (IVD) Margins in Japan and Australia911
5.4.14.2 Local Players Competing with International Players by offering Cheap Products911
5.5 Market Characterization, South and Central America, 2002 2016911
5.5.1 Brazil In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 2009912
5.5.2 Brazil In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 2016931
5.5.3 Argentina In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 2009941
5.5.4 Argentina In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 2016951
5.5.5 Mexico In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 2009961
5.5.6 Mexico In-Vitro Diagnostics (IVD) Market, Revenues ($m), 2009 2016971
5.5.7 South and Central America In-Vitro Diagnostics (IVD) Market, Market Drivers981
5.5.7.1 Economic Stability in the Region to Increase Spending On Healthcare981
5.5.7.2 Laboratory Consolidation to Push Automation in High Volume Testing Centers981
5.5.8 South and Central America In-Vitro Diagnostics (IVD) Market, Market Restraints981
5.5.8.1 Price Sensitivity and Increasing Competition from Local Players a Growing Threat for International Players in the Region981
5.6 Market Characterization, Middle East and Africa, 2002 2016991
5.6.1 Israel In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 2009991
5.6.2 Israel In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 20161001
5.6.3 South Africa In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 20091011
5.6.4 South Africa In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 20161021
5.6.5 Middle East and Africa In-Vitro Diagnostics (IVD) Market, Market Drivers1031
5.6.5.1 Rising Incidence of Drug Resistance to Lead To Growing Use of In Vitro Diagnostics to Contain Spread of Infections1031
5.6.6 Middle East and Africa In-Vitro Diagnostics (IVD) Market, Market Restraints1031
5.6.6.1 Lack of Affordability for Sophisticated In-Vitro Diagnostics1031
6 Global In-Vitro Diagnostics (IVD) Market: Strategic Competitive Assessment10416
6.1 Key Market Participants1041
6.1.1 F. Hoffmann-La Roche Ltd1041
6.1.1.1 Company Overview1041
6.1.1.2 Deals Landscape1041
6.1.1.3 Pipeline Product Portfolio1051
6.1.2 Siemens Medical Solutions1061
6.1.2.1 Company Overview1061
6.1.2.2 Pipeline Product Portfolio1071
6.1.2.3 Deals Landscape1081
6.1.3 Abbott Laboratories1081
6.1.3.1 Company Overview1081
6.1.3.2 Deals Landscape1091
6.1.3.3 Pipeline Product Portfolio1101
6.1.4 Beckman Coulter, Inc.1101
6.1.4.1 Company Overview1102
6.1.4.2 Deals Landscape1121
6.1.4.3 Pipeline Product Portfolio1131
6.1.5 bioMerieux Sa1131
6.1.5.1 Company Overview1131
6.1.5.2 Deals Landscape1141
6.1.5.3 Pipeline Product Portfolio1141
6.1.6 Ortho-Clinical Diagnostics1141
6.1.6.1 Company Overview1141
6.1.6.2 Deals Landscape1151
6.1.6.3 Pipeline Product Portfolio1151
6.1.7 Becton, Dickinson and Company1151
6.1.7.1 Company Overview1151
6.1.7.2 Deals Landscape1161
6.1.7.3 Pipeline Product Portfolio1161
6.1.8 Bio-Rad Laboratories, Inc.1161
6.1.8.1 Company Overview1161
6.1.8.2 Deals Landscape1171
6.1.9 Inverness Medical Innovations, Inc1171
6.1.9.1 Company Overview1171
6.1.9.2 Deals Landscape1181
6.1.9.3 Pipeline Product Portfolio1191
7 Global In-Vitro Diagnostics (IVD) Market: Product Pipeline Analysis1207
Pipeline Products Analysis by Category1201
7.1.1 Pipeline Products Analysis: Immuno Chemistry Market1211
7.1.2 Pipeline Products Analysis: Infectious Immunology1221
7.2 Key Pipeline Products Currently Undergoing Development 1221
7.2.1 Clinical Chemistry Pipeline Products1221
7.2.1.1 ADVIA 1800 neonatal bilirubin test1221
7.2.2 Genetic Testing1221
7.2.2.1 SYNCHRON Anti-dsDNA test1221
7.2.2.2 Multiple Sclerosis-Molecular Diagnostic Test1231
7.2.2.3 AttoSense Lupus Panel1231
7.2.2.4 LungSentryGx-Genetic Predisposition to Lung Cancer Risk1231
7.2.3 Haematology1231
7.2.3.1 Clondiag HIV Molecular Device1231
7.2.3.2 CD4Now BioChip1231
7.2.3.3 Diagnostic Microarrays-Acute Myeloid Leukemia1241
7.2.4 Immunochemistry1241
7.2.4.1 Biomarkers for Alzheimer s disease1241
7.2.4.2 Next Generation Triage CardioProfilER1241
7.2.4.3 Triage Stroke Panel1241
7.2.4.4 NuroPro Blood Test1241
7.2.4.5 AmpliChip p53 Test1241

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand" Jan 31, 2010. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/The-Future-of-the-In-Vitro-Diagnostics-Market-to-2016-Increasing-Diagnostic-Procedures-Drive-Demand-2115-26>
  
APA:
GBI Research Reports. (2010). The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand Jan 31, 2010. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/The-Future-of-the-In-Vitro-Diagnostics-Market-to-2016-Increasing-Diagnostic-Procedures-Drive-Demand-2115-26>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.